| Jun 3, 2025 |
Jun 5, 2025 |
RHYTHM PHARMACEUTICALS, INC.
|
CEO |
Sell |
15.0
|
-43,620
|
-17.77%
|
✓
|
$2.8M |
| Feb 16, 2025 |
Feb 19, 2025 |
RHYTHM PHARMACEUTICALS, INC.
|
CEO |
Sell |
35.0
|
-9,896
|
-4.69%
|
✓
|
$566.2K |
| Feb 1, 2025 |
Feb 4, 2025 |
RHYTHM PHARMACEUTICALS, INC.
|
CEO |
Sell |
38.8
|
-4,278
|
-2.20%
|
✓
|
$254.2K |
| Aug 27, 2024 |
Aug 29, 2024 |
Trevi Therapeutics, Inc.
|
Director |
Sell |
26.3
|
-4,555
|
-1.28%
|
✗
|
$13.4K |
| Mar 19, 2024 |
Mar 19, 2024 |
RHYTHM PHARMACEUTICALS, INC.
|
CEO |
Sell |
10.0
|
-45,494
|
-20.67%
|
✓
|
$1.8M |
| Feb 1, 2024 |
Feb 5, 2024 |
RHYTHM PHARMACEUTICALS, INC.
|
CEO |
Sell |
37.5
|
-4,361
|
-3.48%
|
✓
|
$196.5K |
| Mar 30, 2021 |
Mar 31, 2021 |
RHYTHM PHARMACEUTICALS, INC.
|
CEO |
Buy |
90.0
|
+10,000
|
9.87%
|
✗
|
$201.7K |
| May 9, 2019 |
May 13, 2019 |
Trevi Therapeutics, Inc.
|
Director |
Buy |
87.5
|
+11,250
|
3.30%
|
✗
|
$112.5K |
| Oct 10, 2017 |
Oct 10, 2017 |
RHYTHM PHARMACEUTICALS, INC.
|
Director |
Buy |
97.5
|
+25,000
|
32.75%
|
✗
|
$425K |